Aids Malignancy Consortium

This study is testing whether a smartphone app called Positively Smoke Free - Mobile can help people living with HIV quit smoking. Participants will also receive a low-dose CT scan to screen for lung cancer. The goal is to see if using the app at the time of screening is practica…

This phase 1 trial is testing a CAR-T cell therapy (axicabtagene ciloleucel) in 20 adults with HIV and aggressive B-cell non-Hodgkin lymphoma that has come back or not responded to treatment. The therapy uses a patient's own immune cells, modified to recognize and attack cancer c…

This study tests a drug called ixazomib in 41 people with Kaposi sarcoma, a type of skin cancer. The drug works by blocking enzymes that help cancer cells grow. The main goal is to see how many people's tumors shrink or disappear.

This study looks at whether it's practical to do surgery for a type of eye cancer (OSSN) in people with HIV in Sub-Saharan Africa. About 84 participants will have the tumor removed and be checked for up to a year. The goal is to see if a larger study can be done safely and effect…